Acadian Asset Management’s Atara Biotherapeutics ATRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $502K | Sell |
65,155
-49,956
| -43% | -$385K | ﹤0.01% | 1135 |
|
|
2025
Q1 | $682K | Sell |
115,111
-9,362
| -8% | -$55.5K | ﹤0.01% | 1010 |
|
|
2024
Q4 | $1.66M | Sell |
124,473
-4,671
| -4% | -$62.1K | ﹤0.01% | 814 |
|
|
2024
Q3 | $1.05M | Buy |
129,144
+9,774
| +8% | +$79.4K | ﹤0.01% | 900 |
|
|
2024
Q2 | $1.01M | Buy |
119,370
+13,823
| +13% | +$117K | ﹤0.01% | 981 |
|
|
2024
Q1 | $1.83M | Buy |
105,547
+34,925
| +49% | +$606K | 0.01% | 681 |
|
|
2023
Q4 | $904K | Buy |
70,622
+49,246
| +230% | +$630K | ﹤0.01% | 890 |
|
|
2023
Q3 | $789K | Sell |
21,376
-6,812
| -24% | -$251K | ﹤0.01% | 908 |
|
|
2023
Q2 | $1.13M | Buy |
+28,188
| New | +$1.13M | ﹤0.01% | 849 |
|
|
2023
Q1 | – | Sell |
-18,492
| Closed | -$1.52M | – | 1738 |
|
|
2022
Q4 | $1.52M | Sell |
18,492
-19,724
| -52% | -$1.62M | 0.01% | 747 |
|
|
2022
Q3 | $3.61M | Buy |
+38,216
| New | +$3.61M | 0.02% | 489 |
|
|
2020
Q3 | – | Sell |
-2,323
| Closed | -$846K | – | 2165 |
|
|
2020
Q2 | $846K | Buy |
+2,323
| New | +$846K | ﹤0.01% | 1022 |
|
|
2017
Q2 | – | Sell |
-143
| Closed | -$73K | – | 1438 |
|
|
2017
Q1 | $73K | Buy |
+143
| New | +$73K | ﹤0.01% | 1174 |
|